TCR sequencing sheds light on tumor immune interactions in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) stands as the dominant form of liver cancer, ranking as the fourth leading cause of cancer-related deaths globally.

EMA fast-tracks review of AstraZeneca sipavibart to stop Covid

In a Phase III trial, the asset was demonstrated to be effective in preventing symptomatic Covid-19 in immunocompromised individuals. Credit: Andrii Vodolazhskyi / Shutterstock. The

July 2, 2024

Exclusive: After discovering antibiotics with AI, a 31-year-old first-time CEO raises $17M to fight aging

Jim Collins, the famed MIT professor and a godfather of the synthetic biology field, describes Felix Wong as one of the most talented researchers to

October 3, 2024

First crystal structure of alternative DNA shape from the insulin gene revealed

The first crystal structure of an alternative DNA shape from the insulin gene has been revealed by a UCL-led research team.

September 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.